Wallace H, Wick J, Neuen BL, Buizen L, et al. Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset. Diabetes Obes Metab 2025 Jul 16. doi: 10.1111/dom.16608.
PMID: 40667713